320 related articles for article (PubMed ID: 24214971)
1. Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.
Jeong AL; Lee S; Park JS; Han S; Jang CY; Lim JS; Lee MS; Yang Y
J Biol Chem; 2014 Jan; 289(1):28-40. PubMed ID: 24214971
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation.
Eto M; Elliott E; Prickett TD; Brautigan DL
J Biol Chem; 2002 Nov; 277(46):44013-20. PubMed ID: 12221103
[TBL] [Abstract][Full Text] [Related]
3. CIP2A modulates cell-cycle progression in human cancer cells by regulating the stability and activity of Plk1.
Kim JS; Kim EJ; Oh JS; Park IC; Hwang SG
Cancer Res; 2013 Nov; 73(22):6667-78. PubMed ID: 23983103
[TBL] [Abstract][Full Text] [Related]
4. The role of Polo-like kinase 1 in the inhibition of centrosome separation after ionizing radiation.
Zhang W; Fletcher L; Muschel RJ
J Biol Chem; 2005 Dec; 280(52):42994-9. PubMed ID: 16157594
[TBL] [Abstract][Full Text] [Related]
5. Cep68 can be regulated by Nek2 and SCF complex.
Man X; Megraw TL; Lim YP
Eur J Cell Biol; 2015; 94(3-4):162-72. PubMed ID: 25704143
[TBL] [Abstract][Full Text] [Related]
6. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM
EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219
[TBL] [Abstract][Full Text] [Related]
7. Dishevelled is a NEK2 kinase substrate controlling dynamics of centrosomal linker proteins.
Cervenka I; Valnohova J; Bernatik O; Harnos J; Radsetoulal M; Sedova K; Hanakova K; Potesil D; Sedlackova M; Salasova A; Steinhart Z; Angers S; Schulte G; Hampl A; Zdrahal Z; Bryja V
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9304-9. PubMed ID: 27486244
[TBL] [Abstract][Full Text] [Related]
8. CIP2A inhibits PP2A in human malignancies.
Junttila MR; Puustinen P; Niemelä M; Ahola R; Arnold H; Böttzauw T; Ala-aho R; Nielsen C; Ivaska J; Taya Y; Lu SL; Lin S; Chan EK; Wang XJ; Grènman R; Kast J; Kallunki T; Sears R; Kähäri VM; Westermarck J
Cell; 2007 Jul; 130(1):51-62. PubMed ID: 17632056
[TBL] [Abstract][Full Text] [Related]
9. NIMA-related kinase 2 (Nek2), a cell-cycle-regulated protein kinase localized to centrosomes, is complexed to protein phosphatase 1.
Helps NR; Luo X; Barker HM; Cohen PT
Biochem J; 2000 Jul; 349(Pt 2):509-18. PubMed ID: 10880350
[TBL] [Abstract][Full Text] [Related]
10. Protein phosphatase-1alpha regulates centrosome splitting through Nek2.
Mi J; Guo C; Brautigan DL; Larner JM
Cancer Res; 2007 Feb; 67(3):1082-9. PubMed ID: 17283141
[TBL] [Abstract][Full Text] [Related]
11. The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers.
Fujiki H; Sueoka E; Watanabe T; Suganuma M
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2339-2349. PubMed ID: 30341686
[TBL] [Abstract][Full Text] [Related]
12. Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells.
Khanna A; Kauko O; Böckelman C; Laine A; Schreck I; Partanen JI; Szwajda A; Bormann S; Bilgen T; Helenius M; Pokharel YR; Pimanda J; Russel MR; Haglund C; Cole KA; Klefström J; Aittokallio T; Weiss C; Ristimäki A; Visakorpi T; Westermarck J
Cancer Res; 2013 Nov; 73(22):6757-69. PubMed ID: 24072747
[TBL] [Abstract][Full Text] [Related]
13. Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A.
Yu HC; Hung MH; Chen YL; Chu PY; Wang CY; Chao TT; Liu CY; Shiau CW; Chen KF
Cell Death Dis; 2014 Jul; 5(7):e1359. PubMed ID: 25077545
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing controls nuclear translocation of the cell cycle-regulated Nek2 kinase.
Wu W; Baxter JE; Wattam SL; Hayward DG; Fardilha M; Knebel A; Ford EM; da Cruz e Silva EF; Fry AM
J Biol Chem; 2007 Sep; 282(36):26431-40. PubMed ID: 17626005
[TBL] [Abstract][Full Text] [Related]
15. CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells.
Tian Y; Chen H; Qiao L; Zhang W; Zheng J; Zhao W; Chen JJ; Zhang W
J Cell Mol Med; 2018 Sep; 22(9):4150-4160. PubMed ID: 29893470
[TBL] [Abstract][Full Text] [Related]
16. Mitotic perturbations induced by Nek2 overexpression require interaction with TRF1 in breast cancer cells.
Lee J; Gollahon L
Cell Cycle; 2013 Dec; 12(23):3599-614. PubMed ID: 24091727
[TBL] [Abstract][Full Text] [Related]
17. Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1.
Mbom BC; Siemers KA; Ostrowski MA; Nelson WJ; Barth AI
Mol Biol Cell; 2014 Apr; 25(7):977-91. PubMed ID: 24501426
[TBL] [Abstract][Full Text] [Related]
18. Chronic Cigarette Smoke Exposure Subdues PP2A Activity by Enhancing Expression of the Oncogene CIP2A.
Nath S; Ohlmeyer M; Salathe MA; Poon J; Baumlin N; Foronjy RF; Geraghty P
Am J Respir Cell Mol Biol; 2018 Dec; 59(6):695-705. PubMed ID: 30011381
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of centrosome separation after DNA damage: a role for Nek2.
Fletcher L; Cerniglia GJ; Nigg EA; Yend TJ; Muschel RJ
Radiat Res; 2004 Aug; 162(2):128-35. PubMed ID: 15387139
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.
De P; Carlson J; Leyland-Jones B; Dey N
Oncotarget; 2014 Jul; 5(13):4581-602. PubMed ID: 25015035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
